Skip to main content
. Author manuscript; available in PMC: 2014 Oct 8.
Published in final edited form as: J Am Coll Cardiol. 2013 Jul 31;62(15):10.1016/j.jacc.2013.07.010. doi: 10.1016/j.jacc.2013.07.010

Figure 1.

Figure 1

Teoretical Schema of Heart Failure with Preserved Ejection Fraction Patient Types with Sample Patients, Risk Profiles, and Matched Therapies

HTN = hypertension; NYHA = New York Heart Association functional class; HF = heart failure; LVEF = left ventricular ejection fraction; LAE = left atrial enlargement; DD = diastolic dysfunction; PASP = pulmonary artery systolic pressure; E/e’ = ratio of early mitral inflow to early mitral annular diastolic tissue velocity; CAD s/p CABG = coronary artery disease status-post coronary artery bypass grafting; DOE = dyspnea on exertion; MR = mitral regurgitation; AR = aortic regurgitation; DM2 = type 2 diabetes mellitus; CKD = chronic kidney disease; SOB = shortness of breath; RVH = right ventricular hypertrophy; RV = right ventricular; BNP = B-type natriuretic peptide; If = inward “funny” channel; MRA = mineralocorticoid receptor antagonist; ARNI = angiotensin receptor / neprilysin inhibitor; PDE5 = phosphodiesterase-5